Literature DB >> 629608

Synovial fluid copper and related variables in rheumatoid and degenerative arthritis.

P R Scudder, W McMurray, A G White, T L Dormandy.   

Abstract

Copper, caeruloplasmin, transferrin, albumin, and total protein were measured in the serum and synovial fluid of 40 patients with rheumatoid arthritis and 40 patients with osteoarthrosis. A raised synovial fluid copper and caeruloplasmin have been found to be characteristic of rheumatoid effusions. The relation between copper and caeruloplasmin in synovial fluid differs from that in serum. Synovial fluid caeruloplasmin was increased disproportionately in relation to other plasma proteins present in rheumatoid effusions.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 629608      PMCID: PMC1000193          DOI: 10.1136/ard.37.1.71

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  4 in total

1.  Physicochemical studies of human ceruloplasmin.

Authors:  C B KASPER; H F DEUTSCH
Journal:  J Biol Chem       Date:  1963-07       Impact factor: 5.157

2.  Immunochemical quantitation of antigens by single radial immunodiffusion.

Authors:  G Mancini; A O Carbonara; J F Heremans
Journal:  Immunochemistry       Date:  1965-09

3.  The inhibition of lipid autoxidation by human caeruloplasmin.

Authors:  D J Al-Timimi; T L Dormandy
Journal:  Biochem J       Date:  1977-11-15       Impact factor: 3.857

4.  Serum copper and related variables in rheumatoid arthritis.

Authors:  P R Scudder; D Al-Timimi; W McMurray; A G White; B C Zoob; T L Dormandy
Journal:  Ann Rheum Dis       Date:  1978-02       Impact factor: 19.103

  4 in total
  17 in total

1.  Inhibition of human endothelial cell proliferation in vitro and neovascularization in vivo by D-penicillamine.

Authors:  T Matsubara; R Saura; K Hirohata; M Ziff
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

2.  Non-caeruloplasmin-bound copper ('phenanthroline copper') is not detectable in fresh serum or synovial fluid from patients with rheumatoid arthritis.

Authors:  P G Winyard; H Pall; J Lunec; D R Blake
Journal:  Biochem J       Date:  1987-10-01       Impact factor: 3.857

3.  The acute phase response of C3, C5, ceruloplasmin, and C-reactive protein induced by turpentine pleurisy in the rabbit.

Authors:  P C Giclas; U Manthei; R C Strunk
Journal:  Am J Pathol       Date:  1985-07       Impact factor: 4.307

4.  Caeruloplasmin concentration and oxidase activity in polyarthritis.

Authors:  J S Dixon; M Greenwood; J R Lowe
Journal:  Rheumatol Int       Date:  1988       Impact factor: 2.631

5.  Ceruloplasmin reduces the adhesion and scavenges superoxide during the interaction of activated polymorphonuclear leukocytes with endothelial cells.

Authors:  C Broadley; R L Hoover
Journal:  Am J Pathol       Date:  1989-10       Impact factor: 4.307

Review 6.  Copper and zinc body levels in inflammation: an overview of the data obtained from animal and human studies.

Authors:  R Milanino; M Marrella; R Gasperini; M Pasqualicchio; G Velo
Journal:  Agents Actions       Date:  1993-07

7.  Copper and zinc status in rats with acute inflammation: focus on the inflamed area.

Authors:  R Milanino; M Marrella; U Moretti; E Concari; G P Velo
Journal:  Agents Actions       Date:  1988-07

Review 8.  Copper and inflammation--a possible rationale for the pharmacological manipulation of inflammatory disorders.

Authors:  R Milanino; A Conforti; L Franco; M Marrella; G Velo
Journal:  Agents Actions       Date:  1985-09

9.  Immunosuppression by D-penicillamine in vitro. Inhibition of human T lymphocyte proliferation by copper- or ceruloplasmin-dependent generation of hydrogen peroxide and protection by monocytes.

Authors:  P E Lipsky
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

10.  Inhibition of prostaglandin action and bone resorption by copper.

Authors:  J M Katz; S J Skinner; T Wilson; D H Gray
Journal:  Ann Rheum Dis       Date:  1984-12       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.